Days | NM | NM + AEHE | DM | DM + LAEHE | DM + HAEHE | DM + Gli |
|---|
Day 0 Body weights (g) | 169.3 ± 6.2 | 170.6 ± 6.9 | 172.4 ± 6.0 | 174.1 ± 6.5 | 169.6 ± 7.1 | 173.0 ± 6.8 |
Day 14 Body weights (g) | 211.6 ± 12.1 | 207.0 ± 10.0 | 181.1 ± 9.4a
| 193.5 ± 13.1a,b
| 203.3 ± 12.6a,b
| 209.4 ± 12.9b
|
Day 28 Body weights (g) | 302.3 ± 8.6 | 297.8 ± 11.0 | 226.3 ± 9.8a
| 251.0 ± 10.2a,b
| 291.3 ± 12.1b
| 292.2 ± 10.5b
|
- Values are expressed as mean ± SD in each group. NM group: normal control rats treated with vehicle alone; NM + AEHE group: normal control rats treated with AEHE (100 mg/kg b.w.); DM group: diabetic control rats treated with vehicle alone; DM + LAEHE group: diabetic rats were given AEHE (100 mg/kg b.w.); DM + HAEHE group: diabetic rats were given AEHE (200 mg/kg b.w.); DM + Gli group: diabetic rats were given glibenclamide (30 mg/kg b.w.). aindicates statistical significance of P < 0.01 compared to the NM group; bindicates statistical significance of P < 0.01 compared to the DM group.
